Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Juárez-Sánchez, Raquel
1802  Ergebnisse:
Personensuche X
?
1

Effect of ibrutinib on CCR7 expression and functionality in..:

Mateu-Albero, Tamara ; Juárez-Sánchez, Raquel ; Loscertales, Javier...
Cancer Immunology, Immunotherapy.  71 (2021)  3 - p. 627-636 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Evaluation of Natalizumab Pharmacokinetics and Pharmacodyna..:

Serra López-Matencio, Jose M. ; Pérez García, Yaiza ; Meca-Lallana, Virginia...
Frontiers in Neurology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
3

Targeting cancer homing into the lymph node with a novel an..:

Cuesta-Mateos, Carlos ; Juárez-Sánchez, Raquel ; Mateu-Albero, Tamara...
mAbs.  13 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
4

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC..:

Cuesta-Mateos, Carlos ; Fuentes, Patricia ; Schrader, Alexandra...
Biomarker Research.  8 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

Evaluation of therapeutic targeting of CCR7 in acute graft-..:

Cuesta-Mateos, Carlos ; Portero-Sainz, Itxaso ; García-Peydró, Marina...
Bone Marrow Transplantation.  55 (2020)  10 - p. 1935-1945 , 2020
Link: https://doi.org/10.1038/..
 
?
6

Polyanionic carbosilane dendrimers as a new adjuvant in com..:

Relaño-Rodríguez, Ignacio ; Juárez-Sánchez, Raquel ; Pavicic, Carolina..
Journal of Nanobiotechnology.  17 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
7

Evaluation of Natalizumab Pharmacokinetics and Pharmacodyna..:

Serra López-Matencio, Jose M ; Pérez García, Yaiza ; Meca-Lallana, Virginia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529019/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC..:

Cuesta-Mateos, Carlos ; Fuentes, Patricia ; Schrader, Alexandra...
Biomarker Research.  , 2021
Link: http://hdl.handle.net/10..
 
?
9

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC..:

Cuesta-Mateos, Carlos ; Fuentes, Patricia ; Schrader, Alexandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585232/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC..:

Cuesta-Mateos, Carlos ; Fuentes, Patricia ; Schrader, Alexandra...
Publisher's version.  , 2020
Link: http://hdl.handle.net/10..
 
?
11

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC..:

Cuesta-Mateos, Carlo ; Fuentes, Patricia ; Schrader, Alexandra...
10.1186/s40364-020-00234-z.  , 2020
Link: http://hdl.handle.net/10..
 
?
12

Polyanionic carbosilane dendrimers as a new adjuvant in com..:

Relaño-Rodríguez, Ignacio ; Juárez-Sánchez, Raquel ; Pavicic, Carolina..
http://hdl.handle.net/10668/13998.  , 2019
Link: http://hdl.handle.net/10..
 
?
13

Evaluation of Natalizumab Pharmacokinetics and Pharmacodyna..:

Jose M. Serra López-Matencio ; Yaiza Pérez García ; Virginia Meca-Lallana...
https://www.frontiersin.org/articles/10.3389/fneur.2021.716548/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
14

Targeting cancer homing into the lymph node with a novel an..:

Carlos Cuesta-Mateos ; Raquel Juárez-Sánchez ; Tamara Mateu-Albero...
https://www.tandfonline.com/doi/10.1080/19420862.2021.1917484.  , 2021
Link: https://doi.org/10.1080/..
 
?
15

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC..:

Carlos Cuesta-Mateos ; Patricia Fuentes ; Alexandra Schrader...
http://link.springer.com/article/10.1186/s40364-020-00234-z.  , 2020
Link: https://doi.org/10.1186/..
 
1-15